Thus, there may be competitionif endogenous GLP-1 is already occupying a receptor, then the fluorescently tagged GLP-1R agonist may not attach and label it
Most GLP-1 medications are given via subcutaneous injection, which means an injection under the skin but not in the muscle
AT-R: Writing original draft
The potential role of GLP-1 agonists in psychiatric disorders: a paradigm shift in mental health treatment
Hamed K, Alosaimi MN, Ali BA, Alghamdi A, Alkhashi T, Alkhaldi SS, Altowarqi NA, Alzahrani H, Alshehri AM, Alkhaldi RK, Alqahtani KW, Alharbi NH, Alhulayfi HF, Sharifi SY, Dighriri IM (2024) Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature Review
Additionally, GLP-1 RA users had a higher prevalence of psychiatric comorbidity and more often received psychotropics compared with SGLT-2 and DPP-4 inhibitor users (20% in GLP-1 RA users vs 13% in SGLT-2 inhibitor users and 14% in DPP-4 inhibitor users, respectively)
